In theory, making biopharmaceuticals 24/7—or close to it—could reduce production costs. Various models suggest switching from batch to continuous mode would cut the cost of producing almost all types ...
On a conceptual level, the benefits of “twenty-four seven” drug production are obvious. The ability to make more product, more quickly, and more efficiently will increase access to medicines and help ...
MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq:SSYS), the 3D printing and additive manufacturing solutions company, took a significant step into low-volume, continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results